Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

The hunt for better biomarkers in Neuroendocrine Cancers

The hunt for better biomarkers in Neuroendocrine Cancers

Bevere et al (2023) An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide. Diagnostics 2023, 13, 2820. This article reviews the challenges associated with diagnosing and managing neuroendocrine neoplasms (NENs), a diverse group of...

read more